Q&A

How Tools And Technologies Bring Advanced Therapies To Market

Molecular Genetic Therapy iStock-1289215513

Companies like Pall, Cytiva, and Precision NanoSystems – one of the newest additions to the Danaher Life Sciences portfolio – can provide all of the technologies and expertise necessary to manufacture a drug. All scientists need to focus on is discovery.

Dr. James Taylor, Co-Founder and General Manager of Precision NanoSystems, and Dr. Clive Glover, General Manager, Gene Therapy, Pall answer questions about industry trends and the tools to support the development of RNA vaccines and therapeutics.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene